CLN3, the protein associated with batten disease: Structure, function and localization

被引:100
作者
Phillips, SN
Benedict, JW
Weimer, JM
Pearce, DA
机构
[1] Univ Rochester, Sch Med & Dent, Ctr Aging & Dev Biol, Rochester, NY 14642 USA
[2] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY USA
[3] Univ Rochester, Sch Med & Dent, Interdept Program Neurosci, Rochester, MN USA
[4] Univ Rochester, Sch Med & Dent, Dept Neurol, Rochester, MN USA
关键词
Batten disease; CLN3; neurodegeneration; lysosomal function;
D O I
10.1002/jnr.20367
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Batten disease, an inherited neurodegenerative storage disease affecting children, results from the autosomal recessive inheritance of mutations in Cln3. The function of the CLN3 protein remains unknown. A key to understanding the pathology of this devastating disease will be to elucidate the function of CLN3 at the cellular level. CLN3 has proven difficult to study as it is predicted to be a membrane protein expressed at relatively low levels. This article is a critical review of various approaches used in examining the structure, trafficking, and localization of CLN3. We conclude that CLN3 is likely resident in the lysosomal/endosomal membrane. Different groups have postulated conflicting orientations for CLN3 within this membrane. In addition, CLN3 undergoes several post-translational modifications and is trafficked through the encloplasmic reticulum and Golgi. Recent evidence also suggests that CLN3 traffics via the plasma membrane. Although the function of this protein remains elusive, it is apparent that genetic alterations in C1n3 may have a direct affect on lysosomal function. (C) 2005 Wiley-Liss, Inc.
引用
收藏
页码:573 / 583
页数:11
相关论文
共 40 条
[1]   Cln3Δex7/8 knock-in mice with the common JNCL mutation exhibit progressive neurologic disease that begins before birth [J].
Cotman, SL ;
Vrbanac, V ;
Lebel, LA ;
Lee, RL ;
Johnson, KA ;
Donahue, LR ;
Teed, AM ;
Antonellis, K ;
Bronson, RT ;
Lerner, TJ ;
MacDonald, ME .
HUMAN MOLECULAR GENETICS, 2002, 11 (22) :2709-2721
[2]   The subcellular location of the yeast Saccharomyces cerevisiae homologue of the protein defective in the juvenile form of batten disease [J].
Croopnick, JB ;
Choi, HC ;
Mueller, DM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 250 (02) :335-341
[3]   Characterization of Cln3p, the gene product responsible for juvenile neuronal ceroid lipofuscinosis, as a lysosomal integral membrane glycoprotein [J].
Ezaki, J ;
Takeda-Ezaki, M ;
Koike, M ;
Ohsawa, Y ;
Taka, H ;
Mineki, R ;
Murayama, K ;
Uchiyama, Y ;
Ueno, T ;
Kominami, E .
JOURNAL OF NEUROCHEMISTRY, 2003, 87 (05) :1296-1308
[4]   CLN3 protein regulates lysosomal pH and alters intracellular processing of Alzheimer's amyloid-β protein precursor and cathepsin D in human cells [J].
Golabek, AA ;
Kida, E ;
Walus, M ;
Kaczmarski, W ;
Michalewski, M ;
Wisniewski, KE .
MOLECULAR GENETICS AND METABOLISM, 2000, 70 (03) :203-213
[5]   Expression studies of CLN3 protein (Battenin) in fusion with the green fluorescent protein in mammalian cells in vitro [J].
Golabek, AA ;
Kaczmarski, W ;
Kida, E ;
Kaczmarski, A ;
Michalewski, MP ;
Wisniewski, KE .
MOLECULAR GENETICS AND METABOLISM, 1999, 66 (04) :277-282
[6]   Batten disease:: evaluation of CLN3 mutations on protein localization and function [J].
Haskell, RE ;
Carr, CJ ;
Pearce, DA ;
Bennett, MJ ;
Davidson, BL .
HUMAN MOLECULAR GENETICS, 2000, 9 (05) :735-744
[7]   Intracellular trafficking of the JNCL protein CLN3 [J].
Haskell, RE ;
Derksen, TA ;
Davidson, BL .
MOLECULAR GENETICS AND METABOLISM, 1999, 66 (04) :253-260
[8]   Elevated lysosomal pH in neuronal ceroid lipofuscinoses (NCLs) [J].
Holopainen, JM ;
Saarikoski, J ;
Kinnunen, PKJ ;
Järvelä, I .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2001, 268 (22) :5851-5856
[9]   A model for Batten disease protein CLN3: Functional implications from homology and mutations [J].
Janes, RW ;
Munroe, PB ;
Mitchison, HM ;
Gardiner, RM ;
Mole, SE ;
Wallace, BA .
FEBS LETTERS, 1996, 399 (1-2) :75-77
[10]   Defective intracellular transport of CLN3 is the molecular basis of Batten disease (JNCL) [J].
Järvelä, I ;
Lehtovirta, M ;
Tikkanen, R ;
Kyttälä, A ;
Jalanko, A .
HUMAN MOLECULAR GENETICS, 1999, 8 (06) :1091-1098